Stocks
Anika Therapeutics (ANIK) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 531.3% | 376.5% | 602.4% | 602.4% | 467.6% | ||||
| Changes by years, y/y, % | -908pp | -155pp | -376pp | 0pp | +9.0% | ||||
Anika Therapeutics. R&D/CAPEX, %
Anika Therapeutics. R&D/CAPEX, changes, pp
Anika Therapeutics (ANIK) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 412.2% | 451.5% | 217.4% | 595.7% | 467.6% | |||
| Changes by years, y/y, % | +106pp | -153pp | -394pp | -1 051pp | -456pp | |||
| Changes by quarters, q/q, % | 0pp | +39pp | -234pp | -217pp | ||||
